The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
In silico approaches to patient selection: Credentialing elraglusib as a novel treatment in metastatic melanoma resistant to checkpoint inhibitors.
 
Joseph McDermott
Employment - Lantern Pharma
 
Taylor Weiskittel
Employment - Actuate Therapeutics
Consulting or Advisory Role - Actuate Therapeutics
 
Brittany Borden
No Relationships to Disclose
 
Ludimila Cavalcante
Employment - Actuate Therapeutics
Stock and Other Ownership Interests - Actuate Therapeutics
Consulting or Advisory Role - Pliant
 
Francis J. Giles
Employment - Actuate Therapeutics
Stock and Other Ownership Interests - Actuate Therapeutics
 
Benedito A. Carneiro
Consulting or Advisory Role - Eisai; Seagen; Tempus
Research Funding - Abbvie (Inst); Actuate Therapeutics (Inst); Agenus (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Dragonfly Therapeutics (Inst); MiNK Therapeutics (Inst); Pfizer (Inst); Repare Therapeutics (Inst)
 
Hu Li
Employment - Actuate Therapeutics
Consulting or Advisory Role - Actuate Therapeutics; Biogen; Cellarity
 
Andrew Paul Mazar
Employment - Actuate Therapeutics
Leadership - Monopar Therapeutics
Stock and Other Ownership Interests - Actuate Therapeutics; Monopar Therapeutics
Patents, Royalties, Other Intellectual Property - UPAR patents Monopar, GSK-3 patents Actuate